AMPA receptors mediate fast excitatory neurotransmission, contribute to high cognitive processes such as learning and memory and are implicated in numerous psychiatric and neurodegenerative diseases. In particular, AMPA receptors play a key role in epileptogenesis and seizure spread and, thus, have recently emerged as one of the most promising targets for epilepsy therapy. However, development of drugs targeting AMPA receptors has been stalled because of the lack of knowledge about AMPA receptor structure and function. For example, only structures of homotetrameric intact AMPA receptors have been determined, while the overwhelming majority of AMPA receptors in the central nervous system are heterotetramers. A number of noncompetitive inhibitors and ion channel blockers have been identified as promising candidates for drug development but structural mechanisms of their action on AMPA receptors remain largely unexplored. This missing information is absolutely critical for the future structure-based rational drug design. We plan to study structure and function of AMPA receptors using a combination of biophysical and biochemical approaches, including modern crystallographic and cryo-electron microscopy (cryo-EM) techniques, fluorescence-based methods, electrophysiology, kinetic and molecular modeling.
Our specific aims are to (1) obtain structures of heteromeric AMPA receptors, (2) establish the molecular mechanism of noncompetitive inhibition, and (3) build a structural model of ion channel block. To reach our goals, we will optimize AMPA receptor constructs for crystallization and cryo-EM experiments, develop protocols of their expression and purification and solve structures of heterotetrameric AMPA receptors and AMPA receptors in complex with noncompetitive inhibitors and ion channel blockers. To improve our structural models, we will use new methods of structural refinement combined with molecular dynamics (MD) simulations. We will also test our models using a combination of experimental and in silico mutagenesis, whole-cell patch-clamp recordings and MD simulations. To understand the molecular mechanisms of AMPA receptor heteromeric assembly, noncompetitive inhibition and ion channel block, we will perform extensive MD simulations of homo- and heteromeric AMPA receptors in different activation states and in the presence or absence of noncompetitive inhibitors and ion channel blockers. We will combine the results of structural, computational, functional and mutagenesis experiments to propose molecular models of AMPA receptor heteromeric assembly, noncompetitive inhibition and ion channel block. Reaching our research goals will provide molecular level knowledge essential to greatly facilitate design of new molecules that will have a potential to become safe and more efficacious drugs to treat epilepsy and other disorders related to excitatory neurotransmission.

Public Health Relevance

AMPA subtype ionotropic glutamate receptors mediate the majority of excitatory neurotransmission in the central nervous system and their disfunction is associated with devastating neurological diseases, such as Alzheimer's disease, amyotropic lateral sclerosis, epilepsy and ischemia. Our goal is to study AMPA receptor heteromeric assembly, noncompetitive inhibition and ion channel block using a combination of biophysical and biochemical approaches. Our results will advance understanding of AMPA receptor structure and function and help developing new drug design strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS083660-06
Application #
9507503
Study Section
Biophysics of Neural Systems Study Section (BPNS)
Program Officer
Silberberg, Shai D
Project Start
2013-09-30
Project End
2023-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Biochemistry
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Twomey, Edward C; Sobolevsky, Alexander I (2018) Structural Mechanisms of Gating in Ionotropic Glutamate Receptors. Biochemistry 57:267-276
Singh, Appu K; McGoldrick, Luke L; Saotome, Kei et al. (2018) X-ray crystallography of TRP channels. Channels (Austin) 12:137-152
Twomey, Edward C; Yelshanskaya, Maria V; Vassilevski, Alexander A et al. (2018) Mechanisms of Channel Block in Calcium-Permeable AMPA Receptors. Neuron 99:956-968.e4
Singh, Appu K; Saotome, Kei; McGoldrick, Luke L et al. (2018) Structural bases of TRP channel TRPV6 allosteric modulation by 2-APB. Nat Commun 9:2465
Osmakov, Dmitry I; Koshelev, Sergey G; Andreev, Yaroslav A et al. (2018) Proton-independent activation of acid-sensing ion channel 3 by an alkaloid, lindoldhamine, from Laurus nobilis. Br J Pharmacol 175:924-937
McGoldrick, Luke L; Singh, Appu K; Saotome, Kei et al. (2018) Opening of the human epithelial calcium channel TRPV6. Nature 553:233-237
Singh, Appu K; McGoldrick, Luke L; Sobolevsky, Alexander I (2018) Structure and gating mechanism of the transient receptor potential channel TRPV3. Nat Struct Mol Biol 25:805-813
Singh, Appu K; McGoldrick, Luke L; Twomey, Edward C et al. (2018) Mechanism of calmodulin inactivation of the calcium-selective TRP channel TRPV6. Sci Adv 4:eaau6088
Yelshanskaya, Maria V; Mesbahi-Vasey, Samaneh; Kurnikova, Maria G et al. (2017) Role of the Ion Channel Extracellular Collar in AMPA Receptor Gating. Sci Rep 7:1050
Singh, Appu K; Saotome, Kei; Sobolevsky, Alexander I (2017) Swapping of transmembrane domains in the epithelial calcium channel TRPV6. Sci Rep 7:10669

Showing the most recent 10 out of 19 publications